• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植受者血脂异常的饮食管理

DIETARY MANAGEMENT FOR DYSLIPIDEMIA IN LIVER TRANSPLANT RECIPIENTS.

作者信息

Pinto Andressa S, Chedid Marcio F, Guerra Léa T, Cabeleira Daiane D, Kruel Cleber D P

机构信息

Postgraduate Program in Surgical Sciences.

Division of Gastrointestinal Surgery and Liver and Pancreas Transplantation.

出版信息

Arq Bras Cir Dig. 2016 Nov-Dec;29(4):246-251. doi: 10.1590/0102-6720201600040008.

DOI:10.1590/0102-6720201600040008
PMID:28076479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5225864/
Abstract

BACKGROUND

Dyslipidemia occurs in approximately 70% of all liver transplant (LT) recipients, and no prior control studies have demonstrated any dietary intervention to change it.

AIM

To analyze the effects of a dietary intervention on the lipid profile of dyslipidemic LT recipients.

METHODS

All LT recipients with dyslipidemia on clinical follow-up were enrolled. Anthropometric evaluation, food history, body composition (bioimpedance) and assessment of basal metabolism through indirect calorimetry were performed. Patients met with a dietitian and an individualized diet based on estimate of basal metabolism and consisting of 25% of the total energy value in total fat and <200 mg/day of cholesterol was prescribed. Total cholesterol (TC), HDL-cholesterol (HDL), LDL-cholesterol (LDL), triglycerides (TG) and anthropometric measures were measured at baseline and six months after intervention.

RESULTS

Fifty-thee out of 56 patients concluded follow-up; age was 59±10 years; 29 were men (51.8%). The analysis pre- and post-intervention were, respectively: TC 238.9±30 and 165.1±35, p<0.001; LDL 154±33 and 90±29, p<0.001; and TG 168 (IQR=51-200) and 137 (IQR=94-177), p=<0.001. They were all modified at six months following intervention. At baseline, none of the patients had normal TC, and only 12 (22.7%) had optimal/near optimal LDL. Following dietary intervention, 45 patients (84.9%) reached normal TC and 50 (94.4%) had optimal/near optimal LDL. HDL and anthropometric measures were not modified.

CONCLUSIONS

Dietary counseling with prescription of individualized diet based on estimate of basal metabolism through indirect calorimetry was able to manage dyslipidemia in most LT recipients; so, all dyslipidemic LT recipients must be enrolled on a dietary program.

摘要

背景

约70%的肝移植受者会出现血脂异常,此前尚无对照研究表明任何饮食干预可改变这种情况。

目的

分析饮食干预对血脂异常的肝移植受者血脂水平的影响。

方法

纳入所有临床随访中存在血脂异常的肝移植受者。进行人体测量评估、饮食史调查、身体成分分析(生物电阻抗法)以及通过间接测热法评估基础代谢。患者与营养师会面,根据基础代谢估算制定个性化饮食方案,规定总脂肪占总能量值的25%且胆固醇摄入量<200毫克/天。在基线期和干预6个月后测量总胆固醇(TC)、高密度脂蛋白胆固醇(HDL)、低密度脂蛋白胆固醇(LDL)、甘油三酯(TG)以及人体测量指标。

结果

56例患者中有53例完成随访;年龄为59±10岁;29例为男性(51.8%)。干预前后分析结果分别为:TC 238.9±30和165.1±35,p<0.001;LDL 154±33和90±29,p<0.001;TG 168(四分位间距=51 - 200)和137(四分位间距=94 - 177),p =<0.001。干预6个月后这些指标均有改善。基线期,无患者TC正常,仅12例(22.7%)LDL处于最佳/接近最佳水平。饮食干预后,45例患者(84.9%)TC恢复正常,50例(94.4%)LDL处于最佳/接近最佳水平。HDL和人体测量指标未改变。

结论

通过间接测热法估算基础代谢并据此制定个性化饮食方案的饮食咨询能够使大多数肝移植受者的血脂异常得到控制;因此,所有血脂异常的肝移植受者都应参与饮食计划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b811/5225864/ee909767d3fe/0102-6720-abcd-29-04-00246-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b811/5225864/ee909767d3fe/0102-6720-abcd-29-04-00246-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b811/5225864/ee909767d3fe/0102-6720-abcd-29-04-00246-gf1.jpg

相似文献

1
DIETARY MANAGEMENT FOR DYSLIPIDEMIA IN LIVER TRANSPLANT RECIPIENTS.肝移植受者血脂异常的饮食管理
Arq Bras Cir Dig. 2016 Nov-Dec;29(4):246-251. doi: 10.1590/0102-6720201600040008.
2
3
Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.回顾性病历审查结果,以确定接受高剂量调脂药物处方者治疗的患者在实现血脂目标方面的改善情况。
J Manag Care Pharm. 2006 Nov-Dec;12(9):745-51. doi: 10.18553/jmcp.2006.12.9.745.
4
Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study.植物固醇可降低 2 型糖尿病或有发展为 2 型糖尿病风险的血脂异常个体的 LDL 胆固醇和甘油三酯;一项随机、双盲、安慰剂对照研究。
Nutr Diabetes. 2018 May 25;8(1):30. doi: 10.1038/s41387-018-0039-8.
5
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.土耳其成年人血脂异常及相关危险因素的患病率:特拉布宗血脂研究
Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.
6
Effect of the normalization of TSH and free T4 on lipid profile in a pediatric population with primary hypothyroidism.原发性甲状腺功能减退症患儿 TSH 和游离 T4 正常化对血脂谱的影响。
Andes Pediatr. 2021 Feb;92(1):59-66. doi: 10.32641/andespediatr.v92i1.2614. Epub 2021 Feb 22.
7
Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.瑞舒伐他汀对血脂异常合并脑梗死患者血脂及动脉硬化的影响
J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2007-2011. doi: 10.1016/j.jstrokecerebrovasdis.2014.02.028. Epub 2014 Jul 24.
8
Changes in lipid and carbohydrate metabolism under mTOR- and calcineurin-based immunosuppressive regimen in adult patients after liver transplantation.肝移植后成年患者接受 mTOR 和钙调神经磷酸酶为基础的免疫抑制方案后脂类和碳水化合物代谢的变化。
Eur J Intern Med. 2016 Apr;29:104-9. doi: 10.1016/j.ejim.2015.12.022. Epub 2016 Jan 14.
9
10
Bifidobacteria supplementation: effects on plasma lipid profiles in dyslipidemic children.补充双歧杆菌:对血脂异常儿童血浆脂质谱的影响。
Nutrition. 2014 Jul-Aug;30(7-8):831-6. doi: 10.1016/j.nut.2014.01.014. Epub 2014 Feb 15.

引用本文的文献

1
Managing dyslipidemia in solid organ transplant patients.管理实体器官移植患者的血脂异常。
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S93-S95. doi: 10.1016/j.ihj.2024.01.004. Epub 2024 Jan 8.
2
Nutritional Intake after Liver Transplant: Systematic Review and Meta-Analysis.肝移植术后的营养摄入:系统评价和荟萃分析。
Nutrients. 2023 May 26;15(11):2487. doi: 10.3390/nu15112487.
3
Dyslipidemia in Transplant Patients: Which Therapy?移植患者的血脂异常:哪种治疗方法?

本文引用的文献

1
Lipid profile in cirrhotic patients and its relation to clinical outcome.肝硬化患者的血脂谱及其与临床结局的关系。
Arq Bras Cir Dig. 2015 Apr-Jun;28(2):132-5. doi: 10.1590/S0102-67202015000200012.
2
Bariatric surgery (sleeve gastrectomy) after liver transplantation: case report.肝移植后行减重手术(袖状胃切除术):病例报告
Arq Bras Cir Dig. 2014;27 Suppl 1(Suppl 1):81-3. doi: 10.1590/s0102-6720201400s100021.
3
Prevalence and factors associated with dyslipidemia after liver transplantation.
J Clin Med. 2022 Jul 14;11(14):4080. doi: 10.3390/jcm11144080.
4
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients.前蛋白转化酶枯草杆菌蛋白酶/克新9型抑制剂在实体器官移植患者致动脉粥样硬化性血脂异常中的应用
J Clin Med. 2022 Jun 6;11(11):3247. doi: 10.3390/jcm11113247.
5
Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.非酒精性脂肪性肝炎:美国肝脏移植的第二大主要适应症。
Dig Dis Sci. 2017 Oct;62(10):2621-2622. doi: 10.1007/s10620-017-4724-6.
Rev Assoc Med Bras (1992). 2014 Jul;60(4):365-72. doi: 10.1590/1806-9282.60.04.016.
4
Liver cirrhosis.肝硬化。
Lancet. 2014 May 17;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28.
5
Perioperative nutritional therapy in liver transplantation.肝移植围手术期营养治疗
Surg Today. 2015 Mar;45(3):271-83. doi: 10.1007/s00595-014-0842-3. Epub 2014 Jan 29.
6
[V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis].[第五届巴西血脂异常与动脉粥样硬化预防指南]
Arq Bras Cardiol. 2013 Oct;101(4 Suppl 1):1-20. doi: 10.5935/abc.2013S010.
7
Physical activity and metabolic syndrome in liver transplant recipients.肝移植受者的体力活动与代谢综合征。
Liver Transpl. 2013 Oct;19(10):1125-31. doi: 10.1002/lt.23710. Epub 2013 Aug 15.
8
Resting energy expenditure, body composition, and dietary intake: a longitudinal study before and after liver transplantation.静息能量消耗、身体成分和饮食摄入:肝移植前后的纵向研究。
Transplantation. 2013 Sep;96(6):579-85. doi: 10.1097/TP.0b013e31829d924e.
9
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database.欧洲急性肝衰竭的肝移植:ELTR 数据库 20 多年的结果。
J Hepatol. 2012 Aug;57(2):288-96. doi: 10.1016/j.jhep.2012.03.017. Epub 2012 Apr 18.
10
Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors.肝移植后 20 年幸存者的长期患者预后和生活质量分析。
Ann Surg. 2010 Oct;252(4):652-61. doi: 10.1097/SLA.0b013e3181f5f23a.